NSFMF yields 3.52% · PFE yields 6.13%● Live data
📍 NSFMF pulled ahead of the other in Year 1
Combined, NSFMF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NSFMF + PFE for your $10,000?
Nisshin Seifun Group Inc. engages in the flour milling, processed foods, health foods, biotechnology, pet foods, engineering, and mesh cloth businesses in Japan and internationally. The company manufactures and sells wheat flour, bran, ready-made, and other food-related items; pasta, pasta sauces, premixes, flour for consumer use, heat-and-serve products, dried noodles, and chilled and frozen food products under the NISSHIN, MA?MA, AO-NO-DOKUTSU, and DE CECCO brands; deli foods under the INITIO brand; and health foods, active pharmaceutical ingredients, and pharmaceutical products. It also manufactures and sells pet food for dogs and cats under the JP Style brand; designs and manages manufacturing and processing facilities for grains, food materials, and chemicals; and sells powder processing related equipment. In addition, the company manufactures and sells yeast and other food ingredients, ingredients for diagnostic drugs, and drugs for research; materials for screen-printing, mesh products for industrial use, electronic components, and plastic molding; and deli dishes. Nisshin Seifun Group Inc. was founded in 1900 and is headquartered in Tokyo, Japan.
Full NSFMF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.